NCT05510414 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

An M, Shin ES, Choi MY, Lee Y, Hwang YY, Kim M
Positive Psychological Capital Mediates the Association between Burnout and Nursing Performance Outcomes among Hospital Nurses. Int J Environ Res Public Health. 2020 Aug 18;17(16). pii: E5988. doi: 10.3390/ijerph17165988.
Ciobanu AM, Damian AC, Neagu C
Association between burnout and immunological and endocrine alterations. Rom J Morphol Embryol. 2021 Jan-Mar;62(1):13-18. doi: 10.47162/RJME.62.1.02.
Luo YH, Li H, Plummer V, Cross WM, Lam L, Guo YF, Yin YZ, Zhang JP
An evaluation of a positive psychological intervention to reduce burnout among nurses. Arch Psychiatr Nurs. 2019 Dec;33(6):186-191. doi: 10.1016/j.apnu.2019.08.004. Epub 2019 Aug 19.

Evaluation of a Psychological Capital Intervention to Alleviate Burnout and Regulate Immunity Among Oncology Nurses: a Randomized Controlled Trial

Clinical trial NCT05510414 - References